ArticleBMC nephrology2026
Obinutuzumab versus rituximab in refractory membranous nephropathy: a single-center retrospective cohort study.
Wenhui Lei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it